The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

Disclosure of Conflicts of Interest – Prof. Axel Glasmacher

This is a disclosure report regarding financial/non-financial relationships with for-profit/non-profit healthcare organizations.

Pharmaceutical companies with potential conflict of interest

Member of Board of Directors:

    • 4D Pharma (chairperson)
    • Active Biotech
    • Ryvu Pharmaceuticals

Consultancy:

    • Active Biotech
    • GEMoaB
    • Oncopeptides
    • Nanexa

Stock Ownership (fulfilling the criterion above):

    • 4D Pharma plc
    • Active Biotech
    • Bristol Myers Squibb

 

Other affiliations with potential conflict of interest

No partnerships to disclose

 

Last updated on 7 April 2021

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752

info@cddf.org
Tel: +32 2 880 62 70